Company / Operating Income per Share
Supernus Pharmaceuticals, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.12
FY2025
5-year range
-$1.12 / $1.63
FY2021-FY2025
Trend
-174.9%
vs FY2024
Sector context
#90 of 201
Health Care
What the data says
At $-1.12, Supernus Pharmaceuticals, Inc.'s operating income per share ranks #90 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-1.12 in FY2025 to $3.31 in FY2020.
Based on SEC 10-K filings.
-1.12 in FY2025.
Declined from $-0.09 to $-1.12 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 201 in Health CareTop 45% of 201This company -$1.12 Sector average -$28.56
▼
+96.1% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 174.9% year-over-year.
- Ranks #90 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.12 | -174.9% |
| FY2024 | $1.49 | +1672.1% |
| FY2023 | -$0.09 | -111.0% |
| FY2022 | $0.87 | -46.8% |
| FY2021 | $1.63 | -50.8% |
| FY2020 | $3.31 | +16.4% |
| FY2019 | $2.84 | +168.8% |
| FY2018 | $1.06 | +153.3% |
| FY2017 | $0.42 | +487.3% |
| FY2016 | -$0.11 | -122.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026